Skip to content

Nuvectis Pharma, Inc. NVCT Change in Other Current Assets

Change in Other Current Assets at other companies

LegalZoom.com, Inc. logo
LegalZoom.com, Inc.LZ
-$412K-102%
MetroCity Bankshares logo
MetroCity BanksharesMCBS
-$143K-115%
Hyster-Yale Materials Handling, Inc. logo
Hyster-Yale Materials Handling, Inc.HY
$14M+233%
Archer Aviation logo
Archer AviationACHR
-$1.9M-258%
Unusual Machines logo
Unusual MachinesUMAC
$428K+146%
Monopar Therapeutics logo
Monopar TherapeuticsMNPR
$187.04K-62.7%

Other financials

Income statement

See full
Operating income-$6.3M-12.4%
Net income-$6.1M-13.5%
EPS (diluted)-$0.26+3.7%

Balance sheet

See full
Cash & equivalents$25.1M-15.9%
Total equity$14.2M-32.1%
Total assets$25.4M-15.8%

Cash flow

See full
Operating cash flow-$6.5M-56.0%

Valuation

See full
Market cap$739.27M+335%

Returns & leverage

See full
Return on equity-154.4%+79.4pp
Current ratio2.3×-1.0×

Where this comes from

Reported directly by Nuvectis Pharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentAssets.

The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvectis Pharma, Inc.'s change in other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvectis Pharma, Inc.'s change in other current assets?
Nuvectis Pharma, Inc. (NVCT) reported change in other current assets of $193K in Q1 2026.
How has Nuvectis Pharma, Inc.'s change in other current assets changed year-over-year?
Nuvectis Pharma, Inc.'s change in other current assets decreased by 8.1% year-over-year, from $210K to $193K.
What does change in other current assets mean?
Change in miscellaneous current assets not classified in specific working capital categories.